Health and Healthcare

Amgen : AMGN

All Amgen Articles

704 Articles

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 24, 2020 at 3:36 PM EDT

Why Amgen Is Called to Outperform Large-Cap Biotechs

Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20%…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Jon C. Ogg | Sep 12, 2020 at 10:01 AM EDT

How the Dow Can Still Rise Above 30,000 Before 2021

Here is how the Dow Jones industrial average can still continue to rise and hit the 30,000 mark by year's…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 24, 2020 at 6:25 PM EDT

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Dow Jones industrial average changes look a bit strange, and the real effort behind those changes may simply be…

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jul 29, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate Technology,…

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Lee Jackson | Jul 22, 2020 at 7:28 AM EDT

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate…

Jon C. Ogg | Jul 20, 2020 at 12:32 PM EDT

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Many investors feel like the key stocks in the market have simply gotten away from them, but those fears are…

Jon C. Ogg | Jul 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…

1 … 8 9 10 11 12 … 47

Amgen : AMGN

All Amgen Articles

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

This Week in Coronavirus News

How the Dow Can Still Rise Above 30,000 Before 2021

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Amgen : AMGN

All Amgen Articles

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

This Week in Coronavirus News

How the Dow Can Still Rise Above 30,000 Before 2021

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

Featured Reads

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.